Medication-Assisted Treatment (MAT) for Opioid Use Disorder for People Experiencing Homelessness
Year Developed: 2021
Resource Type: Publication.Primary Audience: Administrative Staff
C-Suite (CEOs, CFOs, CIO, COOs, CMOs, etc.)
Clinicians
Secondary Audience: Board of Directors
Enabling Staff
Outreach Staff
PCAs
Language(s): English
Developed by: National Health Care for the Homeless Council (See other resources developed by this organization).
Resource Summary: This fact sheet presents an analysis of national health center data on buprenorphine-based Medication-Assisted Treatment (MAT) services provided at Health Care for the Homeless health centers in calendar year 2020, underscoring that while more health centers are providing MAT, regions with the highest overdose rates lack sufficient access to buprenorphine.
Resource Details: This fact sheet presents an analysis of national health center data on buprenorphine-based Medication-Assisted Treatment (MAT) services provided at Health Care for the Homeless health centers in calendar year 2020, underscoring that while more health centers are providing MAT, regions with the highest overdose rates lack sufficient access to buprenorphine. It also shows that HCH health centers have an outsize role in providing MAT compared to non-HCH health centers.
Resource Topic: Emerging Issues, Special and Vulnerable Populations, Health Equity
Resource Subtopic: Behavioral Health, Substance Use Disorders, , Policy and Advocacy.
Keywords: Opioids, Persons Experiencing Homelessness, Uniform Data System (UDS).This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $6,625,000 with 0 percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit HRSA.gov.